Valuation: OrganiGram

Market Cap 180M 129M 115M 106M 96.11M 12.22B 185M 1.26B 508M 6.45B 484M 474M 20.44B P/E 2026 *
1.59x
P/E 2027 * 16x
Enterprise Value 180M 129M 115M 106M 96.11M 12.22B 185M 1.26B 508M 6.45B 484M 474M 20.44B EV / Sales 2026 *
0.52x
EV / Sales 2027 * 0.39x
Free-Float
68.94%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer - 2026-01-14
Director of Finance/CFO - 2024-01-07
Chief Operating Officer - 2026-08-18
Director TitleAgeSince
Chairman 65 2018-03-28
Director/Board Member 56 2018-12-16
Director/Board Member 70 2018-12-16
Change 5-day change 1-year change 3-year change Capi.($)
-3.89%+9.83% - - 129M
+3.28%+0.31%+16.53%+30.12% 117B
-1.04%+2.87%+0.28%+100.51% 96.69B
+2.56%-5.40%+96.05%+809.29% 56.02B
+4.52%+1.61%-4.61%+85.70% 30.77B
-0.47%+6.87%+37.26%+68.36% 28.74B
-1.50%+1.86%+38.15%+84.50% 27.18B
-0.82%+1.77%+32.42%+385.60% 21.23B
+2.15%-4.35%-20.55%-14.98% 19.49B
+0.26%-0.64%-6.04%+29.45% 16.82B
Average +0.50%+0.42%+21.06%+175.39% 45.98B
Weighted average by Cap. +1.30%+0.56%+22.94%+178.48%

Financials

2026 *2027 *
Net sales 350M 250M 223M 205M 186M 23.67B 359M 2.45B 985M 12.49B 938M 918M 39.6B 458M 327M 292M 269M 244M 31B 470M 3.21B 1.29B 16.36B 1.23B 1.2B 51.86B
Net income 129M 92.01M 82.2M 75.51M 68.58M 8.72B 132M 901M 363M 4.6B 345M 338M 14.58B 9.4M 6.72M 6M 5.51M 5.01M 636M 9.64M 65.79M 26.47M 336M 25.21M 24.67M 1.06B
Net Debt - -
Logo OrganiGram
Organigram Global Inc. is focused on producing cannabis for adult recreational consumers, as well as developing international business partnerships. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. It operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. It operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - OrganiGram